Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

EYEN

Eyenovia (EYEN)

Eyenovia Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:EYEN
FechaHoraFuenteTítuloSímboloCompañía
06/05/202415:01Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:EYENEyenovia Inc
18/03/202406:12IH Market NewsAnticipation Builds on Wall Street for Federal Reserve’s Upcoming Policy Moves; WTI and Brent See UpticksNASDAQ:EYENEyenovia Inc
11/03/202407:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EYENEyenovia Inc
31/01/202407:13Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:EYENEyenovia Inc
25/01/202406:59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EYENEyenovia Inc
13/11/202315:53Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EYENEyenovia Inc
21/09/202307:00GlobeNewswire Inc.Eyenovia to Participate in Panel Discussion at Cantor Global Healthcare ConferenceNASDAQ:EYENEyenovia Inc
25/08/202311:07Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:EYENEyenovia Inc
29/06/202317:43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EYENEyenovia Inc
27/06/202315:23Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EYENEyenovia Inc
12/05/202308:10Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EYENEyenovia Inc
11/05/202305:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:EYENEyenovia Inc
11/05/202305:02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:EYENEyenovia Inc
27/04/202315:28Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:EYENEyenovia Inc
13/02/202315:07Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:EYENEyenovia Inc
04/01/202315:07Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:EYENEyenovia Inc
23/12/202215:14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:EYENEyenovia Inc
23/12/202205:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:EYENEyenovia Inc
11/11/202205:25TipRanksH.C. Wainwright Sticks to Its Buy Rating for Eyenovia (EYEN)NASDAQ:EYENEyenovia Inc
05/10/202205:30TipRanksAnalysts Offer Insights on Healthcare Companies: Applied Genetic Technologies (AGTC), Eyenovia (EYEN) and ATAI Life Sciences (ATAI)NASDAQ:EYENEyenovia Inc
12/08/202215:03Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:EYENEyenovia Inc
29/06/202208:11Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:EYENEyenovia Inc
30/03/202213:44Edgar (US Regulatory)Annual Report (10-k)NASDAQ:EYENEyenovia Inc
09/03/202207:42Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:EYENEyenovia Inc
07/03/202208:00Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:EYENEyenovia Inc
14/12/202115:06Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:EYENEyenovia Inc
03/10/202108:00TipRanks2 Healthcare Stocks With Big Catalysts in OctoberNASDAQ:EYENEyenovia Inc
29/03/202114:13Edgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:EYENEyenovia Inc
05/10/202006:00Business WireEyenovia to Present Clinical Study Updates at the American Academy of Optometry Annual MeetingNASDAQ:EYENEyenovia Inc
09/09/202007:30GlobeNewswire Inc.Eyenovia to Present at the 22nd Annual H.C. Wainwright Global Investment ConferenceNASDAQ:EYENEyenovia Inc
 Showing the most relevant articles for your search:NASDAQ:EYEN